BioCentury
ARTICLE | Company News

Amgen hematology news

December 24, 2012 8:00 AM UTC

Amgen will pay $612 million to resolve civil liability related to promotional activities for six of its drugs, including anemia drugs Aranesp darbepoetin alfa and Epogen epoetin alfa. The company a...